2016

1. Tanabe K, Kozawa O and Iida H.
cAMP/PKA enhances interleukin-1β-induced interleukin-6 synthesis through STAT3 in glial cells.
Cell. Signal. 2016;28:19-24.

2. Kuroyanagi G, Otsuka T, Yamamoto N, Kainuma S, Ohguchi R, Fujita K, Matsushima-Nishiwaki R, Kozawa O and Tokuda H.
Mimosine suppresses the PGF2α-induced synthesis of osteoprotegerin but not interleukin-6 in osteoblasts.
Int. J. Mol. Med. 2016;37:533-541.

3. Kainuma S, Otsuka T, Kuroyanagi G, Yamamoto N, Matsushima-Nishiwaki R, Kozawa O and Tokuda H.
Possible involvement of AMP-activated protein kinase in PGE1-induced synthesis of osteoprotegerin in osteoblasts.
Exp. Ther. Med. 2016;11:2042-2048.

4. Tsujimoto M, Tokuda H, Kuroyanagi G, Yamamoto N, Kainuma S, Matsushima- Nishiwaki R, Onuma T, Iida Y, Kojima A, Sawada S, Doi T, Enomoto Y, Tanabe K, Akamatsu S, Iida H, Ogura S, Otsuka T, Kozawa O and Iwama T.
AICAR reduces the collagen-stimulated secretion of PDGF-AB and release of soluble CD40 ligand from human platelets: suppression of HSP27 phosphorylation via p44/p42 MAP kinase.
Exp. Ther. Med. 2016;12:1107-1112.

5. Kainuma S, Otsuka T, Kuroyanagi G, Yamamoto N, Matsushima-Nishiwaki R, Kozawa O and Tokuda H.
Regulation by AMP-activated protein kinase of PGE2-induced osteoprotegerin synthesis in osteoblasts.
Mol. Med. Rep. 2016;13:3363-3369.

6. Tsujimoto M, Kuroyanagi G, Matsushima-Nishiwaki R, Kito Y, Enomoto Y, Iida H, Ogura S, Otsuka T, Tokuda H, Kozawa O and Iwama T.
Factor Xa inhibitor suppresses the release of phosphorylated HSP27 from collagen-stimulated human platelets: inhibition of HSP27 phosphorylation via p44/p42 MAP kinase.
PLoS One. 2016;11:e0149077.

7. Okuno M, Yasuda I, Adachi S, Nakashima M, Kawaguchi J, Doi S, Iwashita T, Hirose Y, Kozawa O, Yoshimi N, Shimizu M and Moriwaki H.
The significance of phosphorylated heat shock protein 27 on the prognosis of pancreatic cancer.
Oncotarget. 2016;7:14291-14299.

8. Matsushima-Nishiwaki R, Toyoda H, Nagasawa T, Yasuda E, Chiba N, Okuda S, Maeda A, Kaneoka Y, Kumada T and Kozawa O.
Phosphorylated heat shock protein 20 (HSPB6) regulates transforming growth factor-α-induced migration and invasion of hepatocellular carcinoma cells.
PLoS One. 2016;11:e0151907.

9. Tokuda H, Kuroyanagi G, Tsujimoto M, Matsushima-Nishiwaki R, Akamatsu S, Enomoto Y, Iida H, Otsuka T, Ogura S, Iwama T, Kojima K and Kozawa O.
Thrombin receptor-activating protein (TRAP)-activated Akt is involved in the release of phosphorylated-HSP27 (HSPB1) from platelets in DM patients.
Int. J. Mol. Sci. 2016;17:737.

10. Horibe Y, Adachi S, Yasuda I, Yamauchi T, Kawaguchi J, Kozawa O, Shimizu M and Moriwaki H.
Anticancer effect of arsenite on cell migration, cell cycle and apoptosis in human pancreatic cancer cells.
Oncol. Lett. 2016;12:177-182.

11. Yamamoto N, Tokuda H, Kuroyanagi G, Kainuma S, Matsushima-Nishiwaki R, Fujita K, Kozawa O and Otsuka T.
Heat shock protein 22 (HSPB8) limits TGF-β-stimulated migration of osteoblasts.
Mol. Cell. Endocrinol. 2016;436:1-9.

12. Kainuma S, Tokuda H, Fujita K, Kawabata T, Sakai G, Matsushima-Nishiwaki R, Harada A, Kozawa O and Otsuka T.
Attenuation by incretins of thyroid hormone-stimulated osteocalcin synthesis in osteoblasts.
Biomed. Rep. 2016;5:771-775.

13. Okuno M, Adachi S, Kozawa O, Shimizu M and Yasuda I.
The clinical significance of phosphorylated heat shock protein 27 (HSPB1) in pancreatic cancer.
Int. J. Mol. Sci. 2016;17:137.